Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia

Fig. 2

Median 30, 60, and 90-day mortality in HCAP patients treated with vancomycin or linezolid, HCAP healthcare-associated pneumonia, OR odds ratio, CI confidence interval. The figure depicts crude mortality rates. The adjusted odds ratios and 95 % confidence intervals were derived from multivariable logistic regression models; see text for covariates

Back to article page